Microscopic and electrophysiological changes on regenerating sciatic nerves of rats treated with simvastatin.

UNLABELLED Simvastatin is a hypocholesterolemic agent presumed to cause peripheral neuropathy. We arranged an experimental design which focuses on the effect of simvastatin on peripheral nerves and neural regeneration. Sciatic nerve injury was performed at midthigh region of male wistar rats either by clamp compression or fine cut. Electrophysiological and electron microscopical studies were carried out to assess the effect of simvastatin on peripheral nerve and nerve regeneration. There was no difference between the groups that were given simvastatin and standard regimen in the sciatic nerve when electrophysiological measurements were concerned. However, some of the rats that were given simvastatin show reduction in axoplasm density (intensity) of myelinated nerve fibers and prominent vacuolization of myelin sheath according to light and electron microscopic studies. Sciatic nerve compound muscle activation potential measurements of the animals given simvastatin showed that this drug doesn't have a delaying effect on the peripheral nerve recovery time. Electrophysiological measurements showed that simvastatin did not influence nerve regeneration however it was found to induce severe vacuolization of myelin sheath of the sciatic nerve. It was apparent that the drug induces some form of structural dysfunction as myelin changes supported by electron microscopical studies. CONCLUSION simvastatin was shown to delay regeneration as shown in microscopic studies but still there was no influence on nerve regeneration.

[1]  R. Abbott,et al.  Disorder resembling Guillain–Barré syndrome on initiation of statin therapy , 2004, Muscle & nerve.

[2]  R. Bartt,et al.  Statin‐Associated Peripheral Neuropathy: Review of the Literature , 2004, Pharmacotherapy.

[3]  C. Tan,et al.  Statin therapy and small fibre neuropathy: a serial electrophysiological study , 2003, Journal of the Neurological Sciences.

[4]  J. Hallas,et al.  Statins and risk of polyneuropathy: A case-control study , 2002, Neurology.

[5]  M. Osame,et al.  Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study. , 1998, Toxicology and applied pharmacology.

[6]  P. Ziajka,et al.  Peripheral neuropathy and lipid-lowering therapy. , 1998, Southern medical journal (Birmingham, Ala. Print).

[7]  A. Uchida,et al.  Transient Damage to the Axonal Transport System without Wallerian Degeneration by Acute Nerve Compression , 1997, Experimental Neurology.

[8]  J. Warter,et al.  Enhancement of Mouse Sciatic Nerve Regeneration by the Long Chain Fatty Alcohol,N-Hexacosanol , 1996, Experimental Neurology.

[9]  Y. Uchio [Pathogenesis of acute and chronic compression neuropathy]. , 1995, Nihon Seikeigeka Gakkai zasshi.

[10]  J. Pollard,et al.  Peripheral neuropathy associated with simvastatin. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[11]  S. Mackinnon,et al.  Nerve Crush Injuries—A Model for Axonotmesis , 1994, Experimental Neurology.

[12]  中原 啓一 Experimental simvastatin-induced myopathy in rabbits , 1993 .

[13]  J. England,et al.  Muscle side effects associated with simvastatin therapy , 1990, The Medical journal of Australia.

[14]  A. Lieberman,et al.  Scanning electron microscopy of isolated peripheral nerve fibres. Normal surface structure and alterations proximal to neuromas. , 1971, Zeitschrift für Zellforschung und Mikroskopische Anatomie.